IL112223A0 - Pharmaceutical compositions for the treatment of neurological inflammatory conditions - Google Patents
Pharmaceutical compositions for the treatment of neurological inflammatory conditionsInfo
- Publication number
- IL112223A0 IL112223A0 IL11222395A IL11222395A IL112223A0 IL 112223 A0 IL112223 A0 IL 112223A0 IL 11222395 A IL11222395 A IL 11222395A IL 11222395 A IL11222395 A IL 11222395A IL 112223 A0 IL112223 A0 IL 112223A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pharmaceutical compositions
- inflammatory conditions
- neurological inflammatory
- neurological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK2094 | 1994-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL112223A0 true IL112223A0 (en) | 1995-03-30 |
Family
ID=8088844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11222395A IL112223A0 (en) | 1994-01-04 | 1995-01-02 | Pharmaceutical compositions for the treatment of neurological inflammatory conditions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0735872A1 (en) |
| JP (1) | JPH09507849A (en) |
| CN (1) | CN1142183A (en) |
| AU (1) | AU1311195A (en) |
| BR (1) | BR9506453A (en) |
| CA (1) | CA2180239A1 (en) |
| CZ (1) | CZ198396A3 (en) |
| FI (1) | FI962750A (en) |
| HU (1) | HUT76281A (en) |
| IL (1) | IL112223A0 (en) |
| NO (1) | NO962812L (en) |
| WO (1) | WO1995018615A1 (en) |
| ZA (1) | ZA9530B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1138397A (en) * | 1995-12-15 | 1997-07-14 | Novo Nordisk A/S | Novel method |
| US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2965639A (en) * | 1960-12-20 | New basically substituted azepine | ||
| FI864246A (en) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-SUBSTITUERADE 3-PIPERIDIN- ELLER 3-PYRIDINKARBOXYLSYROR SAMT DERAS DERIVAT. |
| DK93791D0 (en) * | 1991-05-17 | 1991-05-17 | Novo Nordisk As | NEW HETEROCYCLIC CARBOXYLIC ACIDS |
-
1995
- 1995-01-02 IL IL11222395A patent/IL112223A0/en unknown
- 1995-01-03 BR BR9506453A patent/BR9506453A/en not_active Application Discontinuation
- 1995-01-03 WO PCT/DK1995/000003 patent/WO1995018615A1/en not_active Application Discontinuation
- 1995-01-03 EP EP95904410A patent/EP0735872A1/en not_active Withdrawn
- 1995-01-03 CN CN95191801A patent/CN1142183A/en active Pending
- 1995-01-03 CZ CZ961983A patent/CZ198396A3/en unknown
- 1995-01-03 JP JP7518276A patent/JPH09507849A/en active Pending
- 1995-01-03 CA CA002180239A patent/CA2180239A1/en not_active Abandoned
- 1995-01-03 HU HU9601826A patent/HUT76281A/en unknown
- 1995-01-03 AU AU13111/95A patent/AU1311195A/en not_active Abandoned
- 1995-01-04 ZA ZA9530A patent/ZA9530B/en unknown
-
1996
- 1996-07-03 NO NO962812A patent/NO962812L/en unknown
- 1996-07-04 FI FI962750A patent/FI962750A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI962750A0 (en) | 1996-07-04 |
| HU9601826D0 (en) | 1996-09-30 |
| CZ198396A3 (en) | 1997-01-15 |
| CN1142183A (en) | 1997-02-05 |
| BR9506453A (en) | 1997-09-02 |
| NO962812L (en) | 1996-09-04 |
| ZA9530B (en) | 1996-07-04 |
| EP0735872A1 (en) | 1996-10-09 |
| FI962750A (en) | 1996-09-04 |
| HUT76281A (en) | 1997-07-28 |
| CA2180239A1 (en) | 1995-07-13 |
| WO1995018615A1 (en) | 1995-07-13 |
| JPH09507849A (en) | 1997-08-12 |
| AU1311195A (en) | 1995-08-01 |
| NO962812D0 (en) | 1996-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
| IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| EP0759750A4 (en) | Compositions for treatment of chronic inflammatory diseases | |
| GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| HK1042475A1 (en) | Substituted thiazoles for the treatment of inflammation | |
| HUP0004412A3 (en) | Use of heterocyclic vinylethers for the preparation of pharmaceutical compositions treating neurological disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
| IL113263A0 (en) | Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases | |
| EP0777474A4 (en) | Methods for the treatment of inflammatory joint disease | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| IL119225A (en) | Pharmaceutical compositions for the treatment of asthma in mammals | |
| IL113057A0 (en) | Compositions for the treatment of dandruff | |
| GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
| IL105285A0 (en) | Compositions for the treatment of diabetes | |
| HUP9903688A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating autism | |
| IL112223A0 (en) | Pharmaceutical compositions for the treatment of neurological inflammatory conditions | |
| IL120005A0 (en) | Pharmaceutical compositions for the treatment of the eye | |
| HUP9902737A3 (en) | The use of aryl-cyclohexylamine derivatives for preparing pharmaceutical compositions suitable for treatment of cns disorders | |
| ZA944671B (en) | Medicaments for the treatment of inflammatory diseases | |
| HUP9903685A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression | |
| AU5503090A (en) | Imidazodiazepines for the treatment of neurological symptons | |
| IL115886A0 (en) | Pharmaceutical compositions for the treatment of urinary bladder dysfunctions |